These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23497254)

  • 1. Yellow fever vaccination coverage following massive emergency immunization campaigns in rural Uganda, May 2011: a community cluster survey.
    Bagonza J; Rutebemberwa E; Mugaga M; Tumuhamye N; Makumbi I
    BMC Public Health; 2013 Mar; 13():202. PubMed ID: 23497254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004.
    Huhn GD; Brown J; Perea W; Berthe A; Otero H; LiBeau G; Maksha N; Sankoh M; Montgomery S; Marfin A; Admassu M
    Vaccine; 2006 Feb; 24(6):730-7. PubMed ID: 16182416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009.
    Pezzoli L; Conteh I; Kamara W; Gacic-Dobo M; Ronveaux O; Perea WA; Lewis RF
    BMC Public Health; 2012 Jun; 12():415. PubMed ID: 22676225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of yellow fever emergency mass vaccinations among vulnerable groups in Uganda: A qualitative study.
    Huebl L; Nnyombi A; Kihumuro A; Lukwago D; Walakira E; Kutalek R
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012173. PubMed ID: 38739650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
    Monath TP; Nasidi A
    Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow fever control in Cameroon: where are we now and where are we going?
    Wiysonge CS; Nomo E; Mawo J; Ofal J; Mimbouga J; Ticha J; Ndumbe PM
    BMC Med; 2008 Feb; 6():3. PubMed ID: 18261201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009.
    Pezzoli L; Tchio R; Dzossa AD; Ndjomo S; Takeu A; Anya B; Ticha J; Ronveaux O; Lewis RF
    Epidemiol Infect; 2012 Jan; 140(1):14-26. PubMed ID: 21418714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.
    Garske T; Van Kerkhove MD; Yactayo S; Ronveaux O; Lewis RF; Staples JE; Perea W; Ferguson NM;
    PLoS Med; 2014 May; 11(5):e1001638. PubMed ID: 24800812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast.
    Fitzner J; Coulibaly D; Kouadio DE; Yavo JC; Loukou YG; Koudou PO; Coulombier D
    Vaccine; 2004 Nov; 23(2):156-62. PubMed ID: 15531032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing epidemiology of yellow fever virus in Oyo State, Nigeria.
    Bassey BE; Braka F; Onyibe R; Kolude OO; Oluwadare M; Oluwabukola A; Omotunde O; Iyanda OA; Tella AA; Olanike OS
    BMC Public Health; 2022 Mar; 22(1):467. PubMed ID: 35260123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster-sample surveys and lot quality assurance sampling to evaluate yellow fever immunisation coverage following a national campaign, Bolivia, 2007.
    Pezzoli L; Pineda S; Halkyer P; Crespo G; Andrews N; Ronveaux O
    Trop Med Int Health; 2009 Mar; 14(3):355-61. PubMed ID: 19187516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019.
    Nwachukwu William E; Oladejo J; Ofoegbunam CM; Anueyiagu C; Dogunro F; Etiki SO; Dachung BI; Obiekea C; Aderoju B; Akanbi K; Adeyemi IT; Famokun GA; Emelife O; Osamwonyi IW; Ochu CL; Abiode A; Ireye F; Chukwuji M; Ipadeola O; Saiki M; Okudo I; Nwodo D; Oteri JA; Ilori E; Mba N; Ihekweazu C
    BMC Public Health; 2022 Aug; 22(1):1644. PubMed ID: 36042438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and management of the yellow fever epidemic in the Ivory Coast, 2001].
    Akoua-Koffi C; Ekra KD; Kone AB; Dagnan NS; Akran V; Kouadio KL; Loukou YG; Odehouri K; Tagliante-Saracino J; Ehouman A
    Med Trop (Mars); 2002; 62(3):305-9. PubMed ID: 12244930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis.
    Shearer FM; Moyes CL; Pigott DM; Brady OJ; Marinho F; Deshpande A; Longbottom J; Browne AJ; Kraemer MUG; O'Reilly KM; Hombach J; Yactayo S; de Araújo VEM; da Nóbrega AA; Mosser JF; Stanaway JD; Lim SS; Hay SI; Golding N; Reiner RC
    Lancet Infect Dis; 2017 Nov; 17(11):1209-1217. PubMed ID: 28822780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa.
    Hamlet A; Jean K; Yactayo S; Benzler J; Cibrelus L; Ferguson N; Garske T
    Vaccine; 2019 Mar; 37(11):1384-1388. PubMed ID: 30770224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of yellow fever in central and southwestern Uganda, February-may 2016.
    Kwagonza L; Masiira B; Kyobe-Bosa H; Kadobera D; Atuheire EB; Lubwama B; Kagirita A; Katushabe E; Kayiwa JT; Lutwama JJ; Ojwang JC; Makumbi I; Ario AR; Borchert J; Zhu BP
    BMC Infect Dis; 2018 Nov; 18(1):548. PubMed ID: 30390621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.